Why I Order Your Labs — And Why DTC Lab Kits Miss the Point

The direct-to-consumer lab market crossed $3 billion in 2024 and is forecast to roughly double by 2028.^[1] LetsGetChecked, Everlywell, Quest Health, Function Health — what was niche five years ago is now mainstream. Walk into any pharmacy and you can buy a thyroid panel off the shelf. Order online before lunch, swab or finger-prick at home, results in a week.

I understand the appeal. The conventional system is genuinely broken: appointments take months, insurance won't pay for the markers that matter, primary care has 15 minutes and a script pad. DTC labs cut through that. They feel like patient empowerment — and in narrow cases, they are.

But here's what eight years of clinical practice has taught me: for the questions clinical nutrition actually has to answer, DTC kits are the wrong tool. Not because the lab science is wrong — these companies often use the same reference labs (Quest, LabCorp) clinicians use. The problem is upstream of the blood draw. It's the selection of the panel itself. And it's what happens to the results afterward.

Here's the honest case for why I order your labs — through my Fullscript / Rupa Health practitioner portal — instead of pointing you to a self-serve checkout.

The case for DTC labs (and where they fit)

I want to be fair before I argue. DTC labs do three things well:

• Access. If your insurance won't cover an HbA1c and you can't afford a $300 PCP visit just to get it ordered, $39 for a direct test isn't nothing. That's a real win.
• Privacy. Some markers — HIV, STI panels, certain hormonal tests — patients reasonably want to order without involving their primary care chart.
• Routine annual screening. If you already know what you're looking for (cholesterol panel, vitamin D, basic CBC), and you don't need clinical interpretation in context, DTC is fine. It's the same blood, the same machine.

So I'm not anti-DTC. I'm anti using a screening tool for a clinical problem.

What clinical nutrition labs actually have to do

Here's where it falls apart. The panels I order aren't "screening." They're built to answer specific clinical questions about a specific person, on a specific medication, with a specific goal. Three real examples from the kind of patients who book with me:

The GLP-1 patient on month four of tirzepatide

She's lost 28 pounds. She feels good. But she also feels tired in the afternoons, her hair is thinning, and she's started skipping resistance training because "it's not doing anything." DTC kits would let her buy a generic "hormone panel" or "general wellness" panel. Neither would catch what's actually happening.

My practice has a GLP-1 Metabolic Baseline panel as the starting point for patients in her clinical context — but starting point is the operative phrase. After reviewing her intake, I customize: fasting insulin and C-peptide (to see how the medication is reshaping her insulin sensitivity), comprehensive metabolic panel, full thyroid panel including TSH/Free T3/Free T4 (because rapid weight loss can suppress T3 conversion and that's why she's tired^[2]), ferritin and iron studies (women on GLP-1s frequently develop iron deficiency from reduced intake^[3]), vitamin D, B12, magnesium, zinc (the micronutrient floor that gets undercut by reduced food volume), and a high-sensitivity CRP. Plus IGF-1 — because if her lean mass is hemorrhaging, IGF-1 is an early signal worth tracking^[4].

That's the difference. The panel structure exists; we don't reinvent the wheel for every patient. But the panel is adjusted for her — markers added (IGF-1, thyroid panel beyond just TSH), some dropped if not clinically relevant, draw timing optimized for accuracy. There is no DTC equivalent of that process because no DTC platform sees her medication, dose, history, or symptoms before pricing the panel.

The 49-year-old perimenopausal client

She wants to understand her hormones because "everything feels off." DTC platforms sell panels labeled "Female Hormone Health" — usually a 4-5 marker combination of estradiol, progesterone, FSH, and maybe testosterone (typically by immunoassay). The problem: female hormone testing is extraordinarily time-dependent. Drawing FSH on day 18 of a cycle versus day 3 gives wildly different information. Drawing estradiol when she's still cycling versus when she's amenorrheic means completely different clinical interpretations^[5]. And critically: testosterone and estradiol measured by standard immunoassay are notoriously inaccurate at the low concentrations relevant for adult women — the LC-MS/MS (mass spec) assay is the clinical gold standard, but it's almost never what DTC kits use^[6].

None of the DTC platforms ask the right questions to time the draw correctly. They'll happily run the panel on whatever day she ships them blood. The result: a chart of numbers that's clinically meaningless because the context wasn't captured.

My practice's Female Hormone Comprehensive Panel is built specifically for this clinical scenario. It includes 23 tests / 83 biomarkers: sensitive LC-MS/MS estradiol, total + free testosterone (mass spec), SHBG, DHT, estrone, progesterone, DHEA-S, LH/FSH, prolactin, full thyroid (TSH/FT3/FT4/rT3), AM cortisol, vitamin D, iron studies, B12/folate, fasting insulin, HbA1c, lipid panel, CMP. The starter panel is fixed by clinical context; the timing of the draw and any add-ons are individualized after intake. Here's how it compares to a typical DTC "Female Hormone" panel:

The 42-year-old founder who's optimizing

He wants performance data. DTC kits would offer him a generic "executive panel." What he actually needs is different than what his 55-year-old colleague needs. He's already lean, already exercising, already eating well. The marginal value is in finding the things that aren't already optimized — and the things that are silent.

My Executive Metabolic & Cardiovascular Panel is the starter point for him. It adds ApoB (a better cardiovascular predictor than LDL-C and now recommended over LDL-C as the primary CV risk lipid marker by major societies^[7]), Lp(a) (genetic CV risk that conventional panels miss entirely — and that has now reached the threshold of being considered a class IIa recommendation for lifetime measurement^[8]), homocysteine (methylation status), hs-CRP, fasting insulin, GGT (liver fat before ALT rises), and a comprehensive micronutrient panel. After intake I'd drop the "cortisol" and "DHEA" if a DTC kit had suggested them — those are noise without 4-point salivary sampling, and a single morning serum cortisol is rarely actionable for a high-functioning client.

The starter panel is different for him than for the GLP-1 patient or the perimenopausal patient because the clinical question is different. That selection is the work. It can't be automated by a website's quiz.

What happens to results — the second gap

Even if the panel selection were perfect, DTC kits fail at the next step: interpretation in context.

When your DTC result lands in your inbox, it includes reference ranges (often lab-statistical, not clinically optimal), a one-paragraph blurb, and an upsell for a supplement or a follow-up "consultation." There's no integration with your medications, your goals, your training load, your sleep, your previous trends. Most importantly: there's nobody who knows you reading it.

I've had patients bring DTC results to first sessions. The most common pattern: they've spent six months worried about a marker that's totally normal in their clinical context, while missing the marker that is off because they didn't know to look at it. Or worse — they were sold a $200/month supplement stack to "fix" a number that doesn't need fixing.

The blood draw is the cheapest part. The clinical question that decides what to draw, and the interpretation that turns numbers into a plan — that's where the value lives.

The clinician-ordered workflow, in plain terms

Here's what actually happens when you work with me:

1. You book — Discovery Call, single consult, or membership. Any of the three triggers the lab pathway. (Discovery Call is free and 15 minutes, and you don't have to commit to anything else after.)
2. I review your intake. Medications, history, what's prompting the visit, what you're trying to learn. Sometimes I email back a clarifying question or two.
3. I build your panel. Through my Fullscript / Rupa Health practitioner portal, under my NPI and Florida LDN scope. Customized, not pulled off a shelf.
4. Fullscript emails you a secure link. You pay the pass-through lab fee (no markup from me — these are billed at wholesale lab pricing), and you book a draw at any Quest or LabCorp near you. HSA/FSA accepted.
5. Results route to me first. I review them before our session. I flag what matters, contextualize what doesn't, and arrive at our appointment with a plan rather than a number list.
6. We walk through it together. Not "here's your printout — Google the things that look red." Actual interpretation, with reasoning and next steps.

The whole thing takes about 7-10 days from booking to interpretation, depending on draw scheduling.

What this costs (the honest math)

The Foundation Lifestyle Medicine panel runs about $175 through Fullscript. The GLP-1 Metabolic Baseline runs $128. The Executive Metabolic & Cardiovascular panel with all the upgraded markers comes in around $193. Hormone add-on panels run $300-$320 depending on whether male or female.

That's pass-through pricing — I don't mark labs up. Fullscript / Quest bill the patient directly at wholesale lab cost. The clinical work — panel design, ordering under my practitioner credentials, interpretation in context, and the session we use to discuss it — is what the membership fee or per-session fee covers. For active members, the starter panel for your tier is included as part of the engagement; specialty add-ons (hormone panels, certain advanced markers) are at pass-through Fullscript cost if added.

You could absolutely save money ordering generic panels yourself. You'd also be paying for a generic answer to a specific question.

The scope question — can a dietitian even order these?

Yes, in Florida. Under Florida Statute Chapter 468, Part X, licensed Dietitian/Nutritionists (LDN) can order laboratory tests for nutritional assessment within the scope of medical nutrition therapy. Where a specific test requires physician oversight (testosterone replacement panels, certain hormone work), Fullscript / Rupa routes those orders through their ordering-physician network at no additional cost. The clinical interpretation stays with me.

So the legal infrastructure exists. The question is whether you want a clinician thinking about which markers to draw on you, or whether you want to assemble that judgment yourself off a self-serve checkout.

If you want labs through me

Easiest path: book a free 15-minute Discovery Call. We'll spend most of it talking about what you're actually trying to learn. I'll tell you whether labs are even the right next step (sometimes they're not yet), what panel makes sense if so, and what it'll cost. From there you decide whether to engage further.

You'll never get a generic panel from me, and you'll never get results without interpretation. Those are the two things that justify what I charge.